COVID-19 diagnostics for resource-limited settings: Evaluation of "unextracted" qRT-PCR.


Journal

Journal of medical virology
ISSN: 1096-9071
Titre abrégé: J Med Virol
Pays: United States
ID NLM: 7705876

Informations de publication

Date de publication:
01 2021
Historique:
received: 12 05 2020
revised: 16 07 2020
accepted: 17 07 2020
pubmed: 12 8 2020
medline: 5 3 2021
entrez: 12 8 2020
Statut: ppublish

Résumé

The coronavirus disease 2019 (COVID-19) pandemic has created a precipitous increase in the need for molecular diagnostics. Unfortunately, access to RNA extraction reagents can represent a bottleneck for quantitative real-time reverse transcriptase-polymerase chain reaction (qRT-PCR)-based methodologies, stemming from both extraordinary supply-chain stresses and the global reach of the virus into resource-limited settings. To provide flexible diagnostic options for such environments, we report here an "unextracted modification" for qRT-PCR using the Centers for Disease Control's (CDC's) widely utilized primers/probe sets for severe acute respiratory syndrome coronavirus 2 (N1/N2/N3 targeting viral nucleocapsid and RP-control targeting human RNase P). This approach replaces RNA extraction/purification with a heat-inactivation step of viral transport media (VTM), followed by direct inoculation-with or without VTM spin concentration-into PCR master mixes. Using derivatives of care from our clinical workflow, we compared traditional and unextracted CDC methodologies. Although some decrease in analytic sensitivity was evident (by higher C

Identifiants

pubmed: 32779772
doi: 10.1002/jmv.26328
pmc: PMC7405028
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

559-563

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI157827
Pays : United States
Organisme : NHGRI NIH HHS
ID : R42 HG009470
Pays : United States
Organisme : NHGRI NIH HHS
ID : R42HG009470
Pays : United States

Informations de copyright

© 2020 Wiley Periodicals LLC.

Références

Lancet. 2020 Feb 15;395(10223):470-473
pubmed: 31986257
Clin Infect Dis. 2020 Dec 17;71(10):2663-2666
pubmed: 32442256
mBio. 2020 Mar 26;11(2):
pubmed: 32217609
J Clin Microbiol. 1997 Feb;35(2):511-4
pubmed: 9003630
J Virol Methods. 2005 Mar;124(1-2):65-71
pubmed: 15664052
Nat Methods. 2020 May;17(5):465-468
pubmed: 32303725
Am J Clin Pathol. 2020 May 5;153(6):706-708
pubmed: 32227199
Euro Surveill. 2020 Apr;25(14):
pubmed: 32290902
JAMA. 2020 Apr 21;323(15):1437-1438
pubmed: 32150622
J Mol Diagn. 2019 Jul;21(4):623-631
pubmed: 31204166
Clin Chem. 2020 May 1;66(5):664-666
pubmed: 32077933
Lancet Microbe. 2020 May;1(1):e10
pubmed: 32835322
Ann Intern Med. 2020 Jun 2;172(11):726-734
pubmed: 32282894
J Med Virol. 2021 Jan;93(1):559-563
pubmed: 32779772
Emerg Microbes Infect. 2020 Dec;9(1):747-756
pubmed: 32196430

Auteurs

Nicholas M Adams (NM)

Department of Biomedical Engineering, Vanderbilt University, Nashville, Tennessee.

Mindy Leelawong (M)

Department of Biomedical Engineering, Vanderbilt University, Nashville, Tennessee.

Alison Benton (A)

Molecular Infectious Diseases Laboratory, Vanderbilt University Medical Center, Nashville, Tennessee.

Criziel Quinn (C)

Molecular Infectious Diseases Laboratory, Vanderbilt University Medical Center, Nashville, Tennessee.

Frederick R Haselton (FR)

Department of Biomedical Engineering, Vanderbilt University, Nashville, Tennessee.

Jonathan E Schmitz (JE)

Molecular Infectious Diseases Laboratory, Vanderbilt University Medical Center, Nashville, Tennessee.
Department of Pathology, Microbiology, and Immunology, Vanderbilt University, Nashville, Tennessee.
Vanderbilt Institute for Infection, Immunology, and Inflammation, Vanderbilt University Medical Center, Nashville, Tennessee.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH